Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma

NCT06892678 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT06892678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06892678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
Lead sponsor
Montefiore Medical Center
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 7, 2025
Completion date
April 30, 2030
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing's tumor recurrent, osteosarcoma recurrent